Who are LHRH Analogue's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): LHRHa, LHRHA or Surgical Castration.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/lhrh-analogue.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

LHRH Analogue — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LHRH Analogue (LHRH Analogue) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: LHRH agonist. Area: Oncology.

phase 3 LHRH agonist LHRH receptor (GnRH receptor) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

LHRH Analogue (LHRH Analogue) — Alliance Foundation Trials, LLC.. LHRH analogues suppress gonadotropin-releasing hormone signaling to reduce sex hormone production.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
LHRH Analogue TARGET	LHRH Analogue	Alliance Foundation Trials, LLC.	phase 3	LHRH agonist	LHRH receptor (GnRH receptor)
LHRHa	LHRHa	Imperial College London	marketed	LHRH agonist	LHRH receptor (GnRH receptor)
LHRHA or Surgical Castration	LHRHA or Surgical Castration	University of Sydney	phase 3	LHRH agonist / Surgical intervention	LHRH receptor (for LHRH agonist component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (LHRH agonist class)

Alliance Foundation Trials, LLC. · 1 drug in this class
Imperial College London · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LHRH Analogue — Competitive Intelligence Brief. https://druglandscape.com/ci/lhrh-analogue. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing